Clinical Trial Update: Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

View source ↗

Summary

An ongoing clinical trial sponsored by Ensoma is evaluating the prevalence of antibodies and cytokines in participants with Chronic Granulomatous Disease (CGD);…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Snippet

Sponsor: Ensoma | Conditions: Chronic Granulomatous Disease (CGD) | Status: RECRUITING